Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Pozycja w akcjach #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Cena akcji
$0.60736143
Kapitalizacja rynkowa
$58.28M
Zmiana (1 dzień)
-1.04%
Zmiana (1 rok)
-21.09%
Kraj
TW
Handel Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Kategoria

Historia stopy dywidendy dla Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
Stopa dywidendy (TTM) dla Gwo Xi Stem Cell Applied Technology Co. , Ltd (symbol akcji: 6704) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji